67 related articles for article (PubMed ID: 27721875)
1. Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning.
Bhattarai S; Saini G; Li H; Seth G; Fisher TB; Janssen EAM; Kiraz U; Kong J; Aneja R
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201383
[TBL] [Abstract][Full Text] [Related]
2. Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learning.
Bhattarai S; Saini G; Li H; Duanmu H; Seth G; Fisher TB; Janssen EAM; Kiraz U; Kong J; Aneja R
bioRxiv; 2023 Apr; ():. PubMed ID: 37131688
[TBL] [Abstract][Full Text] [Related]
3. Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.
Fisher TB; Saini G; Ts R; Krishnamurthy J; Bhattarai S; Callagy G; Webber M; Janssen EAM; Kong J; Aneja R
Res Sq; 2023 Aug; ():. PubMed ID: 37645881
[TBL] [Abstract][Full Text] [Related]
4. Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis.
LeVee A; Wong M; Flores S; Ruel N; McArthur H; Waisman J; Mortimer J
Oncologist; 2024 Apr; ():. PubMed ID: 38656345
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy.
Zhang W; Li E; Wang L; Lehmann BD; Chen XS
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190123
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
[TBL] [Abstract][Full Text] [Related]
7. Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool.
Krishnamurthy S; Jain P; Tripathy D; Basset R; Randhawa R; Muhammad H; Huang W; Yang H; Kummar S; Wilding G; Roy R
JCO Clin Cancer Inform; 2023 Mar; 7():e2200181. PubMed ID: 36961981
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer.
Ding F; Chen RY; Hou J; Guo J; Dong TY
World J Clin Cases; 2022 Apr; 10(12):3698-3708. PubMed ID: 35647172
[TBL] [Abstract][Full Text] [Related]
9. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer.
Qu F; Li Z; Lai S; Zhong X; Fu X; Huang X; Li Q; Liu S; Li H
Front Oncol; 2021; 11():681905. PubMed ID: 34692474
[TBL] [Abstract][Full Text] [Related]
10. A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer.
Li Y; Zhang J; Wang B; Zhang H; He J; Wang K
Sci Rep; 2021 May; 11(1):11348. PubMed ID: 34059778
[TBL] [Abstract][Full Text] [Related]
11. Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer.
Han Y; Wang J; Xu B
J Cancer; 2021; 12(3):936-945. PubMed ID: 33403050
[No Abstract] [Full Text] [Related]
12. Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors.
Zhang J; Xiao L; Pu S; Liu Y; He J; Wang K
Ann Surg Oncol; 2021 May; 28(5):2632-2645. PubMed ID: 33095360
[TBL] [Abstract][Full Text] [Related]
13. Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
Cuello-López J; Fidalgo-Zapata A; López-Agudelo L; Vásquez-Trespalacios E
PLoS One; 2018; 13(11):e0207224. PubMed ID: 30427884
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers.
Ruan M; Tian T; Rao J; Xu X; Yu B; Yang W; Shui R
Diagn Pathol; 2018 Aug; 13(1):66. PubMed ID: 30170605
[TBL] [Abstract][Full Text] [Related]
15. Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer.
van la Parra RFD; Tadros AB; Checka CM; Rauch GM; Lucci A; Smith BD; Krishnamurthy S; Valero V; Yang WT; Kuerer HM
Br J Surg; 2018 Apr; 105(5):535-543. PubMed ID: 29465744
[TBL] [Abstract][Full Text] [Related]
16. Comment on "Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer".
Altundag K
J Breast Cancer; 2017 Mar; 20(1):114-115. PubMed ID: 28382104
[No Abstract] [Full Text] [Related]
17. Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Jung YY; Hyun CL; Jin MS; Park IA; Chung YR; Shim B; Lee KH; Ryu HS
J Breast Cancer; 2016 Sep; 19(3):261-267. PubMed ID: 27721875
[TBL] [Abstract][Full Text] [Related]
18. Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
Wang Y; Brodsky AS; Xiong J; Lopresti ML; Yang D; Resnick MB
Clin Breast Cancer; 2018 Jun; 18(3):e373-e379. PubMed ID: 28890185
[TBL] [Abstract][Full Text] [Related]
19. A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.
Zhang F; Huang M; Zhou H; Chen K; Jin J; Wu Y; Ying L; Ding X; Su D; Zou D
Ann Surg Oncol; 2019 Nov; 26(12):3912-3919. PubMed ID: 31359285
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
